Purple Biotech Ltd.PPBTNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank87
Year-over-Year Change
Year-over-year total asset growth rate
Latest
13.62%
↓ 49% vs avg
Percentile
P87
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
26.65%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 13.62% |
| Q2 2025 | -3.42% |
| Q1 2025 | -3.90% |
| Q4 2024 | 5.51% |
| Q3 2024 | -2.66% |
| Q2 2024 | -9.53% |
| Q1 2024 | -10.02% |
| Q4 2023 | -2.14% |
| Q3 2023 | -5.68% |
| Q2 2023 | -9.58% |
| Q1 2023 | -2.82% |
| Q4 2022 | -6.70% |
| Q3 2022 | -5.18% |
| Q2 2022 | -6.87% |
| Q1 2022 | -5.56% |
| Q4 2021 | -4.66% |
| Q3 2021 | -3.74% |
| Q2 2021 | -6.67% |
| Q1 2021 | -2.21% |
| Q4 2020 | 0.00% |
| Q3 2020 | -2.31% |
| Q2 2020 | 0.00% |
| Q1 2020 | 482.84% |
| Q4 2019 | 0.00% |
| Q3 2019 | -14.39% |
| Q2 2019 | 0.00% |
| Q1 2019 | 16.76% |
| Q4 2018 | 0.00% |
| Q3 2018 | -19.88% |
| Q2 2018 | 0.00% |
| Q1 2018 | 29.56% |
| Q4 2017 | 0.00% |
| Q3 2017 | -5.99% |
| Q2 2017 | 0.00% |
| Q1 2017 | 1.15% |
| Q4 2016 | 0.00% |
| Q3 2016 | 64.11% |
| Q2 2016 | 0.00% |
| Q1 2016 | -15.95% |
| Q4 2015 | 602.08% |